NCT02551484

Brief Summary

50 patients will be included for each of the 2 procedures: \- For procedure 1: Patients will be selected during multidisciplinary consultations for amputees who are stabilized with their definitive prosthesis and have returned to their usual place of residence. The aim of this procedure is to show the validity and reproducibility of measurements of tissue oxygenation using NIRS (TcPO2 being the reference measurement), to determine the way in which NIRS measurements are more precise (i.e. in terms of validity and reproductibility) (values at rest with the patient lying perfectly flat or with the amputated limb raised 30°). These patients will require a single visit which will include measurements by NIRS and TCPO2, a walk test and the completion of 2 questionnaires (visual scale). \- For procedure 2: The patients will be included in the initial phase of postamputation rehabilitation, during the period of in-hospital rehabilitation. The main problems of healing and tolerance to the temporary prosthesis arise during this phase. The specific objectives will be: To show that measurement by NIRS predicts the quality of healing in trans-tibial amputees; to show that the zone of uncertainty concerning the predictive values for the viability of the stump is smaller with NIRS than with TcPO2 (better discrimination). NIRS and TCPO2 measurements as well as the evaluation of stump healing will be done 15, 30 and 45 days after the amputation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2013

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2015

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 16, 2015

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2018

Completed
Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

5.8 years

First QC Date

August 20, 2015

Last Update Submit

February 5, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • For procedure 1: the intra-class correlation coefficient between two successive NIRS measurements.

    Baseline

  • For procedure 1: the Cronbach alpha coefficient between the NIRS and TcPO2 measurements (the latter being the gold standard).

    Baseline

  • For procedure 2: NIRS values at the first consultation and the time to complete healing.

    Up to 60 days

  • Procedure 2: NIRS values measured at different sessions and the associated healing evaluation.

    45 days after the amputation

Study Arms (2)

Procedure 1

EXPERIMENTAL

Measures with 60 minutes interval during the consultation of equipment, functional testing, receuil pain.

Device: Measurements using NIRSDevice: TCPO2 measurementsOther: 2-minute walk test

Procedure 2

EXPERIMENTAL

Measuring J15, J30 J 45 and after the different settings functional amputation, pain and tissue oxygenation.

Device: Measurements using NIRSDevice: TCPO2 measurements

Interventions

Procedure 1Procedure 2
Procedure 1Procedure 2
Procedure 1

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All groups:
  • Patients who have agreed to take part in the study
  • Patients with National Health Insurance cover,
  • Patients (men or women aged between 18 and 85 years, presenting unilateral transtibial amputation for PAD.
  • Able to understand simple instructions
  • Procedure 1:
  • Stabilized patients with their definitive prosthesis, with no modification of the prosthesis in the previous 3 months and at least 6 months after the amputation.
  • Definitive prosthesis with a contact socket.
  • Patients able to do a 2-minute walk test.
  • Procedure 2:
  • \- Patients in the initial phase of post-amputation (temporary prosthesis, rehabilitation) following unilateral transtibial amputation.

You may not qualify if:

  • Patients without national health insurance cover.
  • Patients under guardianship.
  • Patients with associated chronic motor deficiency, of a neurological origin (examples: sequelae of stroke, balance and coordination disorders), or osteo-articular disease (examples: knee or hip osteoarthritis), given their secondary functional impact, making it impossible for amputees to walk with a prosthesis.
  • Severe medical disorder that significantly impairs functional abilities (severe heart failure, respiratory failure, non-stabilized metabolic disorders, such as progressive kidney failure) and diseases with an impact on short or medium-term survival (progressive neoplastic disease, non-stabilized systemic disease).
  • Complications, other than microcirculatory, with the stump, able to affect the use of a contact socket: hematoma, formation of cysts, fluid build-up, calcifications of soft tissues, bone spur, infection (skin, abscess), neurinoma, deterioration of the knee joint of the amputated limb, angle of the tibial cut leading to specifically painful osteo-cutaneous impingement, venous thrombosis, abnormal shape of the stump making it unsuitable for a socket (flexum of the knee, "pear shaped" stumps or stumps with severe invaginations )…
  • Local skin disorders in the measurement zone (summit of the antero-external area) of the stump compromising the quality of the signals picked up by the electrode (NIRS and TcPO2) : severe edema, hyperkeratosis, ulceration, inflammatory and infectious phenomena.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de DIJON

Dijon, 21079, France

Location

Related Publications (1)

  • Laroche D, Barnay JL, Tourlonias B, Orta C, Obert C, Casillas JM. Microcirculatory Assessment of Arterial Below-Knee Stumps: Near-Infrared Spectroscopy Versus Transcutaneous Oxygen Tension-A Preliminary Study in Prosthesis Users. Arch Phys Med Rehabil. 2017 Jun;98(6):1187-1194. doi: 10.1016/j.apmr.2016.12.001. Epub 2016 Dec 31.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2015

First Posted

September 16, 2015

Study Start

January 15, 2013

Primary Completion

November 16, 2018

Study Completion

November 16, 2018

Last Updated

February 9, 2026

Record last verified: 2026-02

Locations